glp-1 biosimilar Agonists Market Report 2025-2033, By Product, Molecule, and Geo Biosimilar development requires a paradigm
Description
Takeda J, Seino Y, Tanaka K, et al
Glucagon-like peptide-1 (GLP-1) is a pleiotropic hormone that has a broad role in metabolism regulation, including the stimulation of insulin secretion and appetite suppression (Muller et al., 2019), both of which contribute to diabetes treatment
While older treatments (like Ozempic) mimic only one hormone, Mounjaro mimics two: GLP-1 and GIP
Great analysis, Jack Shuang Hou
---- No subscriptions or hidden fees
